Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Gross Profit (2018 - 2025)

TransMedics (TMDX) has 8 years of Gross Profit data on record, last reported at $93.4 million in Q4 2025.

  • For Q4 2025, Gross Profit rose 29.72% year-over-year to $93.4 million; the TTM value through Dec 2025 reached $362.8 million, up 38.43%, while the annual FY2025 figure was $362.8 million, 38.43% up from the prior year.
  • Gross Profit reached $93.4 million in Q4 2025 per TMDX's latest filing, up from $84.6 million in the prior quarter.
  • Across five years, Gross Profit topped out at $96.6 million in Q2 2025 and bottomed at $3.8 million in Q3 2021.
  • Average Gross Profit over 5 years is $43.3 million, with a median of $38.7 million recorded in 2023.
  • Peak YoY movement for Gross Profit: decreased 25.11% in 2021, then surged 380.12% in 2022.
  • A 5-year view of Gross Profit shows it stood at $7.0 million in 2021, then skyrocketed by 196.35% to $20.7 million in 2022, then soared by 131.48% to $47.9 million in 2023, then soared by 50.27% to $72.0 million in 2024, then increased by 29.72% to $93.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $93.4 million in Q4 2025, $84.6 million in Q3 2025, and $96.6 million in Q2 2025.